Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...
Ginebra San Miguel continues to show strong financial performance in 2024 despite challenges from the Philippine Sin Tax Law.
Innscor Africa, currently the second largest counter by market capitalisation on the Victoria Falls Stock Exchange (VFEX), ...
The chief commercial officer of Virgin Atlantic hopes competitors will “start taking us more seriously now” after the airline ...
Earnings before interest and taxes (EBIT) is a useful financial metric. Here's what investors need to know about it.
Weleda, a Swiss company that produces natural cosmetics, homeopathic and anthroposophical remedies, is considering production ...
Vinci: Acquisition of Airports Supports Our Narrow Moat Rating Amid Toll Road Concession Uncertainty
Vinci’s strategy to extend the maturity of its concession portfolio by adding freeheld or long-dated airport concessions will help the business earn maintainable economic profits. The group's ...
Kitron updates its financial outlook due to strong demand within the Defence/Aerospace market sector along with a gradual recovery in other segments. At this time, Kitron expects revenues for the full ...
Weleda AG, the global market leader in certified natural cosmetics and anthroposophic medicines, can look back on a very ...
Now that the JNJ stock has seen a 7% fall, does the current price point make it attractive? Going by what you pay per dollar ...
Crocs Inc. (CROX) may have a reputation for making unsightly footwear, but there’s definitely nothing unsightly about the ...
Virgin Atlantic said record revenues have helped it to a pre-tax profit of £20 million ($26 million) for 2024, its first return to profitability since 2016.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results